The Thai pharmaceutical industry is characterized by its expanding yet challenging landscape. Amidst growing medical tourism and strong R&D centers in the Asia Pacific region, issues related to patent protection, counterfeit drugs, and innovation recognition are increasingly imperative for pharmaceutical companies. In preparing a special report on the Thai pharmaceutical and healthcare sectors for Pharmaceutical Executive, Focus Reports asked Darani Vachanavuttivong, Tiziana Sucharitkul, and Alan Adcock, partners at Tilleke & Gibbins, to discuss challenges in these sectors, and how Tilleke & Gibbins is helping its pharmaceutical clients overcome such critical issues.
Pharmaceutical Executive is a monthly magazine for senior executives of leading pharmaceutical companies worldwide. Focus Reports is an independent publisher of country reports, focused on the pharmaceutical industry, and based on a wide range of analyses from interviews with government officials, manufacturers, leading multinational corporations, and experts.
The full Pharmaceutical Executive report on Thailand will be released in the weeks ahead. For a transcript of the Focus Reports interview, please click on the PDF below.